Carasent ASA
OSE:CARA
Carasent ASA
Cost of Revenue
Carasent ASA
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Carasent ASA
OSE:CARA
|
Cost of Revenue
-kr45.1m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
5%
|
Csam Health Group AS
OSE:CSAM
|
Cost of Revenue
-kr33.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Patientsky Group AS
OSE:PSKY
|
Cost of Revenue
-kr32.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
N
|
Nordhealth AS
OSE:NORDH
|
Cost of Revenue
-€4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Codelab Capital AS
OSE:CODE
|
Cost of Revenue
-kr32.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Carasent ASA's Cost of Revenue?
Cost of Revenue
-45.1m
NOK
Based on the financial report for Mar 31, 2024, Carasent ASA's Cost of Revenue amounts to -45.1m NOK.
What is Carasent ASA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
5%
Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Carasent ASA have been -42% over the past three years , -45% over the past five years , and 5% over the past ten years .